View Item 

Show simple item record

A survey of pediatric hematology/oncology specialists regarding management of central line associated venous thrombosis
dc.contributor.authorWitmer, Char M.
dc.contributor.authorSauck, Emily
dc.contributor.authorRaffini, Leslie J.
dc.date.accessioned2017-06-16T20:12:40Z
dc.date.available2018-08-28T15:28:59Zen
dc.date.issued2017-07
dc.identifier.citationWitmer, Char M.; Sauck, Emily; Raffini, Leslie J. (2017). "A survey of pediatric hematology/oncology specialists regarding management of central line associated venous thrombosis." Pediatric Blood & Cancer 64(7): n/a-n/a.
dc.identifier.issn1545-5009
dc.identifier.issn1545-5017
dc.identifier.urihttps://hdl.handle.net/2027.42/137422
dc.description.abstractCentral venous catheters (CVCs) account for the largest proportion of thrombotic events in pediatric patients. Questions remain regarding adequate treatment and prevention methods. We surveyed pediatric hematology/oncology specialists, using hypothetical cases to assess management strategies for acute CVC thrombosis and secondary prevention. Survey respondents varied in the use of the thrombophilia evaluation (33.3%, 41/123) and duration of treatment (6 weeks: 54.1%, 66/122). Secondary CVC prophylaxis was utilized by 36.6% (45/123) of respondents and by 24.4% (30/123) but only if there was a documented thrombophilia. This heterogeneity highlights the need for clinical studies to address these important clinical questions.
dc.publisherWiley Periodicals, Inc.
dc.subject.othersurvey
dc.subject.otherthrombosis
dc.subject.otherpediatric
dc.subject.othercentral venous catheter
dc.titleA survey of pediatric hematology/oncology specialists regarding management of central line associated venous thrombosis
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137422/1/pbc26383_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137422/2/pbc26383.pdf
dc.identifier.doi10.1002/pbc.26383
dc.identifier.sourcePediatric Blood & Cancer
dc.identifier.citedreferenceAndrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood. 1994; 83: 1251 – 1257.
dc.identifier.citedreferenceVidal E, Sharathkumar A, Glover J, Faustino EV. Central venous catheter‐related thrombosis and thromboprophylaxis in children: A systematic review and meta‐analysis. J Thromb Haemost. 2014; 12: 1096 – 1109.
dc.identifier.citedreferenceSchroeder AR, Axelrod DM, Silverman NH, Rubesova E, Merkel E, Roth SJ. A continuous heparin infusion does not prevent catheter‐related thrombosis in infants after cardiac surgery. Pediatr Crit Care Med. 2010; 11: 489 – 495.
dc.identifier.citedreferenceRuud E, Holmstrom H, De Lange C, Hogstad EM, Wesenberg F. Low‐dose warfarin for the prevention of central line‐associated thromboses in children with malignancies–A randomized, controlled study. Acta Paediatr. 2006; 95: 1053 – 1059.
dc.identifier.citedreferenceMassicotte P, Julian JA, Gent M, et al. An open‐label randomized controlled trial of low molecular weight heparin for the prevention of central venous line‐related thrombotic complications in children: The PROTEKT trial. Thromb Res. 2003; 109: 101 – 108.
dc.identifier.citedreferenceGoldenberg NA, Abshire T, Blatchford PJ, et al. Multicenter randomized controlled trial on duration of therapy for thrombosis in children and young adults (the Kids‐DOTT trial): Pilot/feasibility phase findings. J Thromb Haemost. 2015; 13: 1597 – 1605.
dc.identifier.citedreferenceSchulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995; 332: 1661 – 1665.
dc.identifier.citedreferenceBaglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010; 149: 209 – 220.
dc.identifier.citedreferenceMonagle P, Chan AK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest. 2012; 141: e737S – e801S.
dc.identifier.citedreferenceMacartney CA, Chan AK. Thrombosis in children. Semin Thromb Hemost. 2011; 37: 763 – 761.
dc.identifier.citedreferenceKuhle S, Massicotte P, Chan A, et al. Systemic thromboembolism in children. Data from the 1‐800‐NO‐CLOTS Consultation Service. Thromb Haemost. 2004; 92: 722 – 728.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
pbc26383_am.pdf
Size:
410.7KB
Format:
PDF
View/Open
Name:
pbc26383.pdf
Size:
156.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.